Compounds > 1-hydroxy-3-amino-2-pyrrolidone
Page last updated: 2024-10-21

1-hydroxy-3-amino-2-pyrrolidone and Lesion of Sciatic Nerve

1-hydroxy-3-amino-2-pyrrolidone has been researched along with Lesion of Sciatic Nerve in 2 studies

1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Systemic opioid dosing until adequate analgesia in neuropathic pain may involve intolerable and untreatable side effects."1.31The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats. ( Christensen, D; Kayser, V; Martinez, V, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martinez, V1
Christensen, D2
Kayser, V2
Guilbaud, G1

Other Studies

2 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Lesion of Sciatic Nerve

ArticleYear
The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
    Pain, 2002, Volume: 99, Issue:3

    Topics: Adjuvants, Pharmaceutic; Animals; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine;

2002
The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Neuropharmacology, 2000, Jul-10, Volume: 39, Issue:9

    Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Morphine; Morphi

2000